Matthew W. Davis

High versus low dosing of oral colchicine for early acute gout flare: Twenty‐four–hour outcome of the first multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison colchicine study

Robert Terkeltaub, Daniel E. Furst, Katherine Bennett et al. · Arthritis & Rheumatism · 2010 · 520 citations

Novel evidence‐based colchicine dose‐reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P‐glycoprotein inhibitors

Robert Terkeltaub, Daniel E. Furst, Jennifer L. DiGiacinto et al. · Arthritis & Rheumatism · 2011 · 226 citations

Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019

Christina Price, Frederick L. Altice, Yu Shyr et al. · CHEST Journal · 2020 · 211 citations · Full text

Tocilizumab Treatment, Covid-19 Pandemic, Antiviral Therapy +6

Pharmacokinetics and Tolerability of Lidocaine Patch 5% with Extended Dosing

Arnold R. Gammaitoni, Matthew W. Davis · Annals of Pharmacotherapy · 2002 · 111 citations

Lidocaine Patch 5% Reduces Pain Intensity and Interference with Quality of Life in Patients With Postherpetic Neuralgia: An Effectiveness Trial

Nathaniel P. Katz, Arnold R. Gammaitoni, Matthew W. Davis et al. · Pain Medicine · 2002 · 95 citations